Related Experiment Videos
Cerebral venous thrombosis.
Isabelle Crassard1, Marie-Germaine Bousser
1Department of Neurology, Hôpital Lariboisière, Paris, France.
Summary
Cerebral venous thrombosis (CVT) diagnosis relies on advanced imaging like MRI/MRA. Treatment involves addressing causes, managing symptoms, and using heparin as a primary antithrombotic, even with bleeding complications.
Area of Science:
- Neurology
- Radiology
- Vascular Medicine
Background:
- Cerebral venous thrombosis (CVT) presents with diverse clinical symptoms and onset patterns.
- Accurate diagnosis and prognosis prediction for CVT remain challenging.
- Understanding CVT etiology is crucial for effective management.
Purpose of the Study:
- To outline current diagnostic standards for cerebral venous thrombosis.
- To review established and emerging treatment strategies for CVT.
- To discuss the unpredictable prognosis and management of complications in CVT.
Main Methods:
- Magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA) are primary diagnostic tools.
- Etiological investigation to identify underlying causes of CVT.
- Clinical assessment for symptom management including seizures and intracranial hypertension.
Main Results:
- MRI/MRA combination offers the highest diagnostic accuracy for CVT.
- A significant proportion of CVT cases have unknown etiologies.
- Heparin is the recommended first-line antithrombotic, safe even with hemorrhagic lesions.
Conclusions:
- Early diagnosis and prompt treatment initiation are vital for CVT patients.
- Heparin demonstrates safety and efficacy in CVT management.
- Advanced interventions like thrombolysis or CSF diversion are reserved for severe, refractory cases.